Implications of Gut-Brain Interactions for the Effects of Compounds Derived from Cannabis or Modulating the Endocannabinoid System in Physiological and Pathological Processes

  • 9,151

    Total Downloads

  • 61k

    Total Views and Downloads

About this Research Topic

Submission closed

Background

Growing public interest and concomitant government deregulation of cannabis-derived compounds have shined the spotlight on their physiological effects and therapeutic benefits. Among the major phytocannabinoids, Delta-(9)-tetrahydrocannabinol (THC), the well-known psychoactive cannabis component, and cannabidiol (CBD) its non-psychotropic counterpart, together with their targets in the CNS, have been extensively studied.

The endogenous cannabinoid system (ECS) includes endogenously produced cannabinoids and their receptors, along with synthesis and breakdown enzymes. This system is also represented at several levels along the gastrointestinal tract (GIT) putting it on the frontline during oral intake of exogenous cannabinoids. It is an important player in visceral physiology with essential roles on GIT motility, sensitivity, intestinal permeability, and inflammatory processes along with an apparent function in gut-brain communication (i.e. CB1 expression on vagus nerve afferents, modulation by mental states). These features contributed to making the ECS an attractive target for GI disorders’ treatment, such as inflammatory bowel disease (IBD), and gut-brain axis-linked pathophysiology (e.g. irritable bowel syndrome). Several cannabinoid receptor ligands were suggested as effective in ameliorating IBD symptoms in animal models, however, these results did not translate into successful clinical outcomes. Side effects, presumably emanating from central structures altering brain and energy balance, accounted as major drawbacks, highlighting the need to develop compounds that act peripherally.

While these synthetic drugs are being developed, unraveling the cellular and molecular mechanisms underlying cannabis-derived compounds’ impact along the GIT, is crucial to refining our understanding of their therapeutic potentials and limitations. New research exposing the promiscuous interactions of phytocannabinoids, such as CBD, with receptors and proteins (GPR18, GPR55, TrpV1R, 5-HT1AR, PPAR, etc.) beyond the ECS, and the potential cross-talks between ECS and the systems these receptors engage, opens to conceptualizing a more complex network at play. Meanwhile, the growing availability of minor phytocannabinoids (e.g. CBG, CBN, CBA) is fueling more investigations into the synergies amongst phytocannabinoids, a phenomenon known as the “entourage effect”. Ongoing research into these interactions is expanding this concept to other chemicals present in hemp, and other plants, as well those produced endogenously (e.g. Terpenes, phenolic acids, N-acylethanolamines, N-acyl-neurotransmitters, etc.), known to have functional properties of their own.

A better understanding of the pharmacological, biochemical, and functional interactions of these compounds along the GIT should provide promising grounds to improve current therapeutics by leveraging these synergies. Just as important as understanding these molecular interactions, are studies shedding light onto the genetic, epigenetic, circadian, dietary, microbiotic, and age-related factors, susceptible to modulate these therapeutic effects through the ECS. Understanding the interplays between these factors, systems and cellular pathways along the gut-brain axis could set the stage for more robust, personalized, and precise interventions.

This Research Topic aims to collect the latest molecular, cellular, and pre-clinical research outputs on the impact of cannabis-derived compounds derived from cannabis or other sources on the gut-brain axis fostering hope for new therapeutic outcomes. We welcome authors to address the following topics:

- Mechanistic interactions between diet-microbiota and the ECS.
- Hemp-derived compounds (Cannabinoids, terpenes, phenolic acids etc.) interactions and functional properties along the GIT.
- Experimental evidence supporting the cross-talk between the ECS and other systems (i.e. serotoninergic) throughout the digestive tract.
- Pre-clinical and clinical-based evidence supporting therapeutic applications of drugs leveraging synergies for the treatment of gut-brain axis-linked pathologies.

We hope to contribute to our understanding of the mechanisms underlying the potential contribution of hemp-derived compounds to improving pathologies along the gut-brain axis while pointing out current hurdles and gaps in our knowledge. We anticipate it will spur emerging and future research as we try to close the gap between pre-clinical and clinical outcomes.


Dr. Francesca Borrelli received research grants from GW pharmaceuticals to perform preclinical studies on phytocannabinoids and intestinal diseases. She holds patents on phytocannabinoids and colorectal cancer and inflammatory bowel diseases. The other Topics Editors declare no conflicts of interest with regard to their Research Topic.

Keywords: Phytocannabinoids, Enteric nervous system, Endocannabinoid, Gut-Brain Axis, Microbiota

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and they fall under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

      In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.